Jilin Aotai Pharmaceutical Technology Co., Ltd.

To study the pharmacokinetics of leuprolide acetate injection in healthy humans, explore the characteristics of drug absorption, distribution, metabolism and excretion in the human body, and clarify its pharmacokinetic characteristics, so as to provide a definite experimental basis for the design of clinical dosing regimen and dosage determination of leuprolide acetate injection, and provide a theoretical basis for the dosing regimen of Phase II clinical trials.

To evaluate the efficacy and safety of domestic leuprolide acetate immediate-release injection and leuprolide acetate sustained-release injection in the treatment of prostate cancer.